Clinical Trial

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

Name: Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease — clinical trial record (NCT06924359)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MOIPAD

Recruiting

View on ClinicalTrials.gov →

Summary

With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).

Trial Details

NCT Number	NCT06924359
Lead Sponsor	Peking University First Hospital
Conditions	Alzheimer's Disease (AD)
Enrollment	200 participants
Start Date	2025-03-19
Primary Completion	2027-08-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-11